rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2001-12-28
|
pubmed:abstractText |
Dyshidrotic palmoplantar eczema is a frequent disease often running a chronic relapsing course. Topical glucocorticosteroids form the mainstay of therapy, and alternatives are urgently warranted.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0190-9622
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
73-7
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11756949-Administration, Cutaneous,
pubmed-meshheading:11756949-Adult,
pubmed-meshheading:11756949-Anti-Bacterial Agents,
pubmed-meshheading:11756949-Anti-Inflammatory Agents,
pubmed-meshheading:11756949-Eczema, Dyshidrotic,
pubmed-meshheading:11756949-Female,
pubmed-meshheading:11756949-Foot Dermatoses,
pubmed-meshheading:11756949-Glucocorticoids,
pubmed-meshheading:11756949-Hand Dermatoses,
pubmed-meshheading:11756949-Humans,
pubmed-meshheading:11756949-Immunosuppressive Agents,
pubmed-meshheading:11756949-Male,
pubmed-meshheading:11756949-Middle Aged,
pubmed-meshheading:11756949-Pregnadienediols,
pubmed-meshheading:11756949-Severity of Illness Index,
pubmed-meshheading:11756949-Single-Blind Method,
pubmed-meshheading:11756949-Tacrolimus,
pubmed-meshheading:11756949-Treatment Outcome
|
pubmed:year |
2002
|
pubmed:articleTitle |
Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial.
|
pubmed:affiliation |
Department of Dermatology and Allergy Biederstein, Technical University Munich, Germany. nina.schnopp@lrz.tu-muenchen.de
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|